Property	Value
Status
Version
Ad File
Disable Ads Flag
Environment
Moat Init
Moat Ready
Contextual Ready
Contextual URL
Contextual Initial Segments
Contextual Used Segments
AdUnit
SubAdUnit
Custom Targeting
Ad Events
Invalid Ad Sizes

Marinos C. Dalakas MD, FAAN Advisory Board

Nina F. Schor MD, PhD Advisory Board

See All Experts

featured

Published in Neurology

Journal Scan / Consensus and Guidelines · June 12, 2024

Teratogenesis, Perinatal, and Neurodevelopmental Outcomes After In Utero Exposure to Antiseizure Medications

Neurology

Save Recommend

Sign in to PracticeUpdate

Only registered members have full access to PracticeUpdate content.

Not a member?

Join for free

Disclosure statements are available on the authors' profiles:

L. Gonzalez Castro MD, PhD

Yi Li MD, PhD

Neurology

Teratogenesis, Perinatal, and Neurodevelopmental Outcomes After In Utero Exposure to Antiseizure Medication: Practice Guideline From the AAN, AES, and SMFM

Neurology 2024 Jun 01;102(11)e209279, AM Pack, M Oskoui, S Williams Roberson, DK Donley, J French, EE Gerard, D Gloss, WR Miller, HM Munger Clary, SS Osmundson, B McFadden, K Parratt, PB Pennell, G Saade, DB Smith, K Sullivan, SV Thomas, T Tomson, M Dolan O'Brien, K Botchway-Doe, HM Silsbee, MR Keezer

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Teratogenesis, Perinatal, and Neurodevelopmental Outcomes After In Utero Exposure to Antiseizure Medications

Additional Info

Teratogenesis, Perinatal, and Neurodevelopmental Outcomes After In Utero Exposure to Antiseizure Medication: Practice Guideline From the AAN, AES, and SMFM

Further Reading

2023 US Departments of Veterans Affairs and Defense Clinical Practice Guideline for the Management of Headache

Tremor Severity and Operative Parameters Predict Imbalance in Patients Undergoing Focused Ultrasound Thalamotomy

AHA: GLP-1 RA, SGLT-2i Use Can Lower Risk for MI, Recurrent Stroke in Stroke Survivors

The Presence of Oligoclonal Bands Predicts Conversion to MS in Patients With Isolated Myelitis

Long-Term Safety and Efficacy of Adjunctive Lacosamide in the Treatment of Generalized-Onset Tonic–Clonic Seizures

Diffusion Tensor Imaging Along the Perivascular Space as a Measure of Parkinson's Disease Progression

Neurobehavioral Therapy in Patients With Traumatic Brain Injury and Functional Seizures or Epilepsy

Endovascular Treatment vs Medical Management for Basilar Artery Occlusion With Low to Moderate Symptoms

Multisite Skin Biopsies vs CSF Testing for Prion Seeding Activity in the Diagnosis of Prion Diseases

Rate of Autoimmune Encephalitis Among Children With First-Episode Psychosis

Safety, Tolerability, and Efficacy of Subcutaneous Efgartigimod in Patients With Chronic Inflammatory Demyelinating Polyradiculoneuropathy

Recently Updated